| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 7.21e-06 | 20 | 128 | 4 | GO:0050664 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 2.99e-05 | 10 | 128 | 3 | GO:0016176 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 5.43e-05 | 12 | 128 | 3 | GO:0016175 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 7.23e-05 | 35 | 128 | 4 | GO:0043325 | |
| GeneOntologyMolecularFunction | TRAIL receptor activity | 2.43e-04 | 4 | 128 | 2 | GO:0036463 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | SPRY2 RGL3 NCF1 WASHC1 DENND1C TNFRSF10B TNFRSF10A DENND1A SLIT2 NCOR1 WASH3P FZR1 PLEKHG3 SYDE2 PHACTR4 C4A C4B NCF1C NCF1B PIF1 ARHGAP33 | 2.61e-04 | 1418 | 128 | 21 | GO:0030234 |
| GeneOntologyMolecularFunction | alpha-tubulin binding | 3.44e-04 | 52 | 128 | 4 | GO:0043014 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 3.66e-04 | 95 | 128 | 5 | GO:0016651 | |
| GeneOntologyMolecularFunction | TRAIL binding | 4.03e-04 | 5 | 128 | 2 | GO:0045569 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 9.96e-04 | 316 | 128 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 1.11e-03 | 8 | 128 | 2 | GO:0141039 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 6.82e-09 | 5 | 127 | 4 | GO:0070946 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of bacterium | 3.38e-08 | 16 | 127 | 5 | GO:0070944 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of symbiont cell | 8.87e-08 | 19 | 127 | 5 | GO:0070943 | |
| GeneOntologyBiologicalProcess | neutrophil mediated cytotoxicity | 1.54e-07 | 21 | 127 | 5 | GO:0070942 | |
| GeneOntologyBiologicalProcess | killing by host of symbiont cells | 3.49e-06 | 38 | 127 | 5 | GO:0051873 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 7.84e-06 | 7 | 127 | 3 | GO:0006742 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 7.84e-06 | 7 | 127 | 3 | GO:0070947 | |
| GeneOntologyBiologicalProcess | neutrophil mediated immunity | 1.13e-05 | 48 | 127 | 5 | GO:0002446 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 3.63e-05 | 11 | 127 | 3 | GO:0060264 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 6.23e-05 | 13 | 127 | 3 | GO:0002536 | |
| GeneOntologyBiologicalProcess | defense response to fungus | 7.69e-05 | 71 | 127 | 5 | GO:0050832 | |
| GeneOntologyBiologicalProcess | response to yeast | 1.74e-04 | 18 | 127 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.75e-04 | 133 | 127 | 6 | GO:0006939 | |
| GeneOntologyBiologicalProcess | response to fungus | 1.81e-04 | 85 | 127 | 5 | GO:0009620 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 2.41e-04 | 20 | 127 | 3 | GO:0002679 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 3.22e-04 | 22 | 127 | 3 | GO:0045986 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 3.22e-04 | 22 | 127 | 3 | GO:0050665 | |
| GeneOntologyCellularComponent | centriole | 9.26e-05 | 172 | 128 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 1.71e-04 | 18 | 128 | 3 | GO:0043020 | |
| GeneOntologyCellularComponent | cell body | BRINP3 NCF1 SMURF1 TXNRD2 SEZ6L2 DENND1A SLIT2 SYN1 KCNQ3 C4A C4B CACNA1G NCF1C NCF1B GABBR1 | 5.67e-04 | 929 | 128 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | BRINP3 NCF1 SMURF1 TXNRD2 SEZ6L2 DENND1A SLIT2 KCNQ3 C4A C4B CACNA1G NCF1C NCF1B GABBR1 | 6.05e-04 | 835 | 128 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | dendrite | BRINP3 NCF1 TXNRD2 DENND1A SLIT2 SYN1 KCNQ3 C4A C4B CACNA1G NCF1C NCF1B GABBR1 ARHGAP33 | 7.88e-04 | 858 | 128 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | BRINP3 NCF1 TXNRD2 DENND1A SLIT2 SYN1 KCNQ3 C4A C4B CACNA1G NCF1C NCF1B GABBR1 ARHGAP33 | 8.06e-04 | 860 | 128 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | symbiont cell surface | 1.02e-03 | 8 | 128 | 2 | GO:0106139 | |
| MousePheno | decreased susceptibility to viral infection | 4.41e-06 | 125 | 105 | 8 | MP:0002410 | |
| MousePheno | abnormal angiotensin I-converting enzyme activity | 8.10e-06 | 6 | 105 | 3 | MP:0013254 | |
| MousePheno | increased angiotensin I-converting enzyme activity | 8.10e-06 | 6 | 105 | 3 | MP:0003184 | |
| MousePheno | liver abscess | 1.41e-05 | 7 | 105 | 3 | MP:0003332 | |
| MousePheno | decreased susceptibility to Riboviria infection | 3.43e-05 | 82 | 105 | 6 | MP:0020914 | |
| MousePheno | impaired granulocyte bactericidal activity | 4.76e-05 | 10 | 105 | 3 | MP:0005074 | |
| MousePheno | decreased susceptibility to infection | 1.27e-04 | 255 | 105 | 9 | MP:0002409 | |
| MousePheno | granulomatous inflammation | 1.47e-04 | 36 | 105 | 4 | MP:0002500 | |
| Domain | N-CoR_GPS2_interact | 4.37e-05 | 2 | 124 | 2 | IPR031557 | |
| Domain | SPIN-2 | 4.37e-05 | 2 | 124 | 2 | IPR029564 | |
| Domain | GPS2_interact | 4.37e-05 | 2 | 124 | 2 | PF15784 | |
| Domain | TNFR_10 | 2.60e-04 | 4 | 124 | 2 | IPR020465 | |
| Domain | Anaphylatoxin_comp_syst | 4.32e-04 | 5 | 124 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 4.32e-04 | 5 | 124 | 2 | IPR001840 | |
| Domain | SPIN/Ssty | 4.32e-04 | 5 | 124 | 2 | IPR003671 | |
| Domain | Spin-Ssty | 4.32e-04 | 5 | 124 | 2 | PF02513 | |
| Domain | ANATO | 8.98e-04 | 7 | 124 | 2 | SM00104 | |
| Domain | - | 8.98e-04 | 7 | 124 | 2 | 3.30.390.30 | |
| Domain | ANAPHYLATOXIN_2 | 8.98e-04 | 7 | 124 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 8.98e-04 | 7 | 124 | 2 | PS01177 | |
| Domain | ANATO | 8.98e-04 | 7 | 124 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 8.98e-04 | 7 | 124 | 2 | IPR000020 | |
| Domain | Pyr_nucl-diS_OxRdtase_dimer | 1.19e-03 | 8 | 124 | 2 | IPR004099 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.19e-03 | 8 | 124 | 2 | IPR019565 | |
| Domain | FAD/NAD-linked_Rdtase_dimer | 1.19e-03 | 8 | 124 | 2 | IPR016156 | |
| Domain | Thiol-ester_cl | 1.19e-03 | 8 | 124 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.19e-03 | 8 | 124 | 2 | IPR019742 | |
| Domain | A2M | 1.90e-03 | 10 | 124 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.90e-03 | 10 | 124 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.90e-03 | 10 | 124 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.90e-03 | 10 | 124 | 2 | PF07677 | |
| Domain | A2M_comp | 1.90e-03 | 10 | 124 | 2 | PF07678 | |
| Domain | A2M_N | 1.90e-03 | 10 | 124 | 2 | PF01835 | |
| Domain | A2M_N | 1.90e-03 | 10 | 124 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.90e-03 | 10 | 124 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.90e-03 | 10 | 124 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.90e-03 | 10 | 124 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.90e-03 | 10 | 124 | 2 | IPR001599 | |
| Domain | MYB_LIKE | 2.03e-03 | 38 | 124 | 3 | PS50090 | |
| Domain | uDENN | 3.78e-03 | 14 | 124 | 2 | SM00800 | |
| Domain | uDENN | 4.34e-03 | 15 | 124 | 2 | PF03456 | |
| Domain | SANT | 4.46e-03 | 50 | 124 | 3 | SM00717 | |
| Domain | DENN | 4.94e-03 | 16 | 124 | 2 | SM00799 | |
| Domain | DENN | 4.94e-03 | 16 | 124 | 2 | PF02141 | |
| Domain | dDENN | 4.94e-03 | 16 | 124 | 2 | PF03455 | |
| Domain | UDENN | 4.94e-03 | 16 | 124 | 2 | PS50946 | |
| Domain | DDENN | 4.94e-03 | 16 | 124 | 2 | PS50947 | |
| Domain | dDENN | 4.94e-03 | 16 | 124 | 2 | SM00801 | |
| Domain | dDENN_dom | 4.94e-03 | 16 | 124 | 2 | IPR005112 | |
| Domain | uDENN_dom | 4.94e-03 | 16 | 124 | 2 | IPR005113 | |
| Domain | DENN | 4.94e-03 | 16 | 124 | 2 | PS50211 | |
| Domain | DENN_dom | 4.94e-03 | 16 | 124 | 2 | IPR001194 | |
| Domain | SANT/Myb | 4.98e-03 | 52 | 124 | 3 | IPR001005 | |
| Domain | C345C | 5.57e-03 | 17 | 124 | 2 | SM00643 | |
| Domain | - | 6.13e-03 | 56 | 124 | 3 | 3.50.50.60 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 6.24e-03 | 18 | 124 | 2 | IPR008930 | |
| Domain | FAD/NAD-binding_dom | 6.44e-03 | 57 | 124 | 3 | IPR023753 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 2.20e-05 | 9 | 92 | 3 | MM14524 | |
| Pathway | REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES | 7.62e-05 | 35 | 92 | 4 | MM14944 | |
| Pubmed | 9.29e-10 | 5 | 130 | 4 | 10714686 | ||
| Pubmed | Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense. | 2.78e-09 | 6 | 130 | 4 | 22163282 | |
| Pubmed | Killing activity of neutrophils is mediated through activation of proteases by K+ flux. | 6.47e-09 | 7 | 130 | 4 | 11907569 | |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 5.10e-08 | 3 | 130 | 3 | 27044504 | |
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 5.10e-08 | 3 | 130 | 3 | 18787174 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 24873968 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 22184329 | ||
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 5.10e-08 | 3 | 130 | 3 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 5.10e-08 | 3 | 130 | 3 | 20142487 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 5.10e-08 | 3 | 130 | 3 | 25565313 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 39357591 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 11435342 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 31118934 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 16041040 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 5.10e-08 | 3 | 130 | 3 | 18703411 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 17307863 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 5.10e-08 | 3 | 130 | 3 | 27829407 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 22376231 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 5.10e-08 | 3 | 130 | 3 | 28274989 | |
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 5.10e-08 | 3 | 130 | 3 | 12364355 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 34557202 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 28467721 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 10670582 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 5.10e-08 | 3 | 130 | 3 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 5.10e-08 | 3 | 130 | 3 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 5.10e-08 | 3 | 130 | 3 | 23328631 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 34572995 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 17114280 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 25989352 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 17404617 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 17332431 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 36592568 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 30504842 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 5.10e-08 | 3 | 130 | 3 | 23965970 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 15513930 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 15033459 | ||
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 5.10e-08 | 3 | 130 | 3 | 20828610 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 20817944 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 36853827 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 23024271 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 21253614 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 15310853 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 31393787 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 10725280 | ||
| Pubmed | Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice. | 5.10e-08 | 3 | 130 | 3 | 34970267 | |
| Pubmed | Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility. | 5.10e-08 | 3 | 130 | 3 | 25689796 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 14993144 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 22050439 | ||
| Pubmed | The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. | 5.10e-08 | 3 | 130 | 3 | 12031896 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 11249873 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 15936744 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 25628043 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 12560337 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 35276443 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 19381132 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 12176908 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 9329953 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 10799876 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 11834706 | ||
| Pubmed | A model of chronic enthesitis and new bone formation characterized by multimodal imaging. | 5.10e-08 | 3 | 130 | 3 | 30045841 | |
| Pubmed | Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease. | 5.10e-08 | 3 | 130 | 3 | 19635825 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 35788118 | ||
| Pubmed | Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation. | 5.10e-08 | 3 | 130 | 3 | 17310103 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 5.10e-08 | 3 | 130 | 3 | 10678931 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 5.10e-08 | 3 | 130 | 3 | 24358335 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 10891396 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 25474113 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 26209274 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 5.10e-08 | 3 | 130 | 3 | 11018074 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 9116268 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 5.10e-08 | 3 | 130 | 3 | 21570954 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 12958309 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 23482812 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 10085000 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 10987289 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 21435178 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 29228045 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 22155727 | ||
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 5.10e-08 | 3 | 130 | 3 | 24576409 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 26645958 | ||
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 5.10e-08 | 3 | 130 | 3 | 24549323 | |
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 5.10e-08 | 3 | 130 | 3 | 20881184 | |
| Pubmed | Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. | 5.10e-08 | 3 | 130 | 3 | 19168575 | |
| Pubmed | NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. | 5.10e-08 | 3 | 130 | 3 | 19503084 | |
| Pubmed | Genetic requirement of p47phox for superoxide production by murine microglia. | 5.10e-08 | 3 | 130 | 3 | 11156938 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 10772875 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 27798190 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 20702812 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 26455429 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 15626477 | ||
| Pubmed | NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. | 5.10e-08 | 3 | 130 | 3 | 19077231 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 22319452 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 16895801 | ||
| Pubmed | Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. | 5.10e-08 | 3 | 130 | 3 | 20690191 | |
| Cytoband | Xp11.1 | 4.76e-05 | 4 | 130 | 2 | Xp11.1 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 4.65e-05 | 16 | 81 | 3 | 14 | |
| GeneFamily | Tudor domain containing|Spindlin family | 1.97e-04 | 5 | 81 | 2 | 1089 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 6.99e-04 | 9 | 81 | 2 | 1234 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.73e-03 | 53 | 81 | 3 | 532 | |
| GeneFamily | DNA helicases | 2.58e-03 | 17 | 81 | 2 | 1167 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR | 3.82e-06 | 22 | 129 | 4 | M39156 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | 6.92e-06 | 200 | 129 | 8 | M6208 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Ptrf|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.63e-06 | 133 | 130 | 6 | a1bc34e5dda4ff4716b857931cc196f6770f58f4 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 177 | 130 | 6 | 9b4c1ca5c6fca9a7a936dad49a04155903ef9c32 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-05 | 179 | 130 | 6 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 188 | 130 | 6 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 189 | 130 | 6 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 192 | 130 | 6 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | proximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.34e-05 | 195 | 130 | 6 | 8592d0332bc82a91e173680cfd1afc5ee189b289 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.34e-05 | 195 | 130 | 6 | c48ff83c48342875f06c6c9e7d5bc6084a992848 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.34e-05 | 195 | 130 | 6 | ae9d61011e95f7840cbb154738c79745fd29943e | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 2.48e-05 | 197 | 130 | 6 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | 410b1a31de21c57d87ca2104f61cf4a7d4dd2f30 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 200 | 130 | 6 | be46efc899d06c55ee297bee3126f69bcdb2048b | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 7.20e-07 | 5 | 124 | 3 | DOID:3265 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.55e-05 | 12 | 124 | 3 | DOID:7148 (implicated_via_orthology) | |
| Disease | heterogeneous nuclear ribonucleoprotein a/b measurement | 1.05e-04 | 4 | 124 | 2 | EFO_0020441 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 1.21e-04 | 23 | 124 | 3 | OBA_2045158 | |
| Disease | Autistic Disorder | 1.22e-04 | 261 | 124 | 7 | C0004352 | |
| Disease | R-6-hydroxywarfarin measurement | 1.23e-04 | 114 | 124 | 5 | EFO_0803327 | |
| Disease | metabolite measurement, diet measurement | 2.32e-04 | 71 | 124 | 4 | EFO_0004725, EFO_0008111 | |
| Disease | progeria (implicated_via_orthology) | 4.82e-04 | 8 | 124 | 2 | DOID:3911 (implicated_via_orthology) | |
| Disease | orofacial cleft | 5.07e-04 | 37 | 124 | 3 | MONDO_0000358 | |
| Disease | epilepsy (is_implicated_in) | 6.19e-04 | 9 | 124 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | Dyskeratosis congenita | 6.19e-04 | 9 | 124 | 2 | cv:C0265965 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 6.87e-04 | 41 | 124 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 6.87e-04 | 41 | 124 | 3 | C0858252 | |
| Disease | HOYERAAL-HREIDARSSON SYNDROME | 7.71e-04 | 10 | 124 | 2 | C1846142 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 7.91e-04 | 43 | 124 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | apolipoprotein A 1 measurement | TCEA3 PDE3B DOK7 GDNF NCOR2 FZR1 LIPG DLEC1 UBASH3B PLIN1 USP1 | 9.20e-04 | 848 | 124 | 11 | EFO_0004614 |
| Disease | Huntington Disease, Late Onset | 1.12e-03 | 12 | 124 | 2 | C0393574 | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 1.12e-03 | 12 | 124 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 1.12e-03 | 12 | 124 | 2 | C0751208 | |
| Disease | longevity | 1.30e-03 | 284 | 124 | 6 | EFO_0004300 | |
| Disease | polyp of colon | 1.71e-03 | 56 | 124 | 3 | MONDO_0021400 | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 1.77e-03 | 15 | 124 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | Dyskeratosis Congenita | 2.02e-03 | 16 | 124 | 2 | C0265965 | |
| Disease | systemic lupus erythematosus | SHROOM3 HLA-DOA NCF1 CHD9 SEZ6L2 ANKRD55 PRR14 C4B GABBR1 NOTCH4 | 2.05e-03 | 799 | 124 | 10 | MONDO_0007915 |
| Disease | Huntington Disease | 2.29e-03 | 17 | 124 | 2 | C0020179 | |
| Disease | inosine measurement | 2.86e-03 | 19 | 124 | 2 | EFO_0010503 | |
| Disease | hemifacial microsomia | 2.86e-03 | 19 | 124 | 2 | MONDO_0015398 | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.10e-03 | 69 | 124 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | pantothenic acid mesurement | 3.17e-03 | 20 | 124 | 2 | EFO_0010519 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 3.17e-03 | 20 | 124 | 2 | OBA_2045071 | |
| Disease | Lupus Erythematosus, Systemic | 3.36e-03 | 71 | 124 | 3 | C0024141 | |
| Disease | osteoarthritis (biomarker_via_orthology) | 3.49e-03 | 21 | 124 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 3.49e-03 | 21 | 124 | 2 | OBA_2045156 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 3.49e-03 | 21 | 124 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AARQTQGRLLPREPA | 46 | A4D1N5 | |
| REPRSQDRRRQQQPL | 696 | Q8NDL9 | |
| SQGERRRRTLPQLPN | 636 | Q5SW79 | |
| LPRAQRRRVGQDPAL | 596 | Q8WVB6 | |
| IRDRVNKLSPPGQRR | 706 | Q76B58 | |
| LQRPRPNIRKTGQRQ | 1576 | A6H8Y1 | |
| RQEGAPPQQSARRDR | 76 | O00230 | |
| REQERSREQGQPRPL | 116 | Q9H0I2 | |
| RPPRVGDTLNLNLRA | 481 | P0C0L5 | |
| RSPRQRNRLPGNLFQ | 26 | O95831 | |
| GLRQRRPLRPQVVTD | 6 | Q9HDC9 | |
| LRTNRVLPAIPSQRR | 581 | Q3KP44 | |
| NRPLRPSRRRQLEEG | 506 | Q8IV53 | |
| VQAQRPLGQRQPRRS | 6 | Q8WXS4 | |
| PSPGFQRQRQRQRRA | 61 | Q76LX8 | |
| INGSPRTPRRGQNRS | 246 | P06400 | |
| LQRTGDPANLNRLRP | 341 | Q5TC82 | |
| RQQQPRARDEAGVPR | 146 | Q9H0J4 | |
| RPQIRLEREQLRTGP | 286 | P14920 | |
| LRPRAQRQTPSGSRE | 411 | Q6P3S6 | |
| GSIIQPQRRRPSLLS | 56 | Q9Y618 | |
| MRTQVNRLGRRPQGP | 831 | A5PL33 | |
| RDPQRRPQDGLRLKS | 3021 | Q9UKN7 | |
| LQSRQQLRSRRHPPT | 916 | Q9UBS5 | |
| LQGPYSDRISPRQRR | 766 | O43525 | |
| VQPRRRRQKQSPDNL | 206 | P11487 | |
| RRIDLNLDISPQRPR | 26 | O14733 | |
| PPQSQIRGRAQSRSR | 761 | Q9H5P4 | |
| KGLNRNSLPTPQLRR | 426 | Q13370 | |
| QRQIKRGAPPRRSSI | 291 | P14598 | |
| FLQQRRRQARPGPQS | 331 | P14598 | |
| QRRSRDVAPLPQRRN | 396 | Q92817 | |
| LEQRQSRRRNLPRPV | 46 | Q9NUL7 | |
| ARRPELNQPARLTLG | 71 | Q9NUL7 | |
| QPRNPGRELNIRRIR | 436 | Q9Y5X9 | |
| LPRRERNRQAAAANP | 86 | P39905 | |
| LLRRAQAPQAPRSRA | 196 | Q9UMN6 | |
| RRAQRLRPQDEPRQG | 41 | Q9UIX4 | |
| NRTAGPPRRNEALAR | 26 | P30559 | |
| LRRQRSQRRSPAEGP | 31 | Q3MIN7 | |
| IGNTLIRRLSQRPTP | 581 | Q8IZ21 | |
| AQRQIKRGAPPRRSS | 291 | A6NI72 | |
| RFLQQRRRQARPGPQ | 331 | A6NI72 | |
| AQRQIKRGAPPRRSS | 266 | A8MVU1 | |
| RFLQQRRRQARPGPQ | 306 | A8MVU1 | |
| LPLNIRNSPFTRGRR | 866 | Q7Z6E9 | |
| APRLAQPRRSLRSAQ | 446 | O60240 | |
| PRQQSDGSLLRSQRP | 971 | O14559 | |
| RDIRTPPLQSERRLQ | 296 | Q9UM11 | |
| QLQASRPDTRRLDRP | 826 | Q3L8U1 | |
| ERSNRSRAINVPPRV | 101 | P06340 | |
| GRSPLAQRPLRRQAA | 2121 | O43497 | |
| REVTTPPNQRRRTLE | 766 | Q99715 | |
| FRRTPVPQQRILSSR | 26 | Q9Y6N8 | |
| EPQSIVPRLRTRNTR | 316 | Q9UK97 | |
| LRPSLNGRRISDPQV | 781 | Q4L180 | |
| PNPRAALERQQLRLR | 101 | Q9BQY9 | |
| QLLRSRRQDRPSKPG | 31 | Q0P5P2 | |
| LREQSRRPPSQNFAR | 221 | Q8N4Y2 | |
| QSAQARLPRGRPRAL | 486 | Q8IYS4 | |
| PRQQDRNIPRGSDII | 121 | Q9UBS4 | |
| NSLALPRRPQNRDSI | 666 | Q8TEH3 | |
| RRNPFARLDNRPRVA | 76 | Q9NYP3 | |
| RRVRRNRNVNPVALP | 116 | P08311 | |
| QIPQNSVTPRRGRRK | 1801 | Q8WYP5 | |
| GPPRTDQQRRTVRCL | 706 | Q8WXE1 | |
| PLRPRQLQEVGRQSS | 321 | Q18PE1 | |
| RATLQPLRGQRRTQD | 111 | D6RIA3 | |
| ARPRRLTQLALAQRP | 61 | Q9Y238 | |
| SRRSQPGQRREPRKI | 701 | O43432 | |
| QNPIAQPLASRRLTR | 31 | Q9NX24 | |
| GPRLSRRILQQARQQ | 51 | Q13895 | |
| RPPRVGDTLNLNLRA | 481 | P0C0L4 | |
| ALQQPRAPRSGRLQE | 736 | Q8NAC3 | |
| PENDLQRGRLSRGPR | 116 | Q8TE04 | |
| RRQRAQPVLDPTGRT | 986 | Q9NZ71 | |
| IQPSRRRNQNRVPLL | 501 | Q5HYW3 | |
| QLRPRVRPQRRAAAA | 46 | A0A3B3IS91 | |
| LSPGGQPRRRQALRT | 26 | Q9H611 | |
| GVLRPRQNRLDSPLS | 1071 | Q5VT97 | |
| QALPRQRQRDASPGR | 416 | P17600 | |
| PPREAAQRLRQATTR | 101 | Q2YD98 | |
| NTPARNRRSPPVRRQ | 111 | Q9H0F5 | |
| RGRTNIQRGPNPVFR | 401 | Q17RD7 | |
| PPQENRDKNLSRRRQ | 181 | Q8TDR4 | |
| PADPSQQGRVRNLRE | 1196 | A1L390 | |
| RTLSPARRQPDVEQR | 621 | Q9H4M7 | |
| QQGRTSEPGRQTRRP | 736 | Q15572 | |
| LNQPRSGSVSLRPRR | 436 | Q8NEA9 | |
| NLRPDVARGLSPREQ | 1626 | O75376 | |
| FRIRRTPARPQLNLT | 446 | Q9BWN1 | |
| RGPQRPDARLLRSQS | 876 | Q8TF72 | |
| KQRGRPSSQPRRNIV | 36 | Q99865 | |
| GARRKNSRRDVQPLP | 151 | Q53LP3 | |
| RVLAQLRGPQPRRRL | 591 | Q6UXD5 | |
| NRPTNNRGQPRTRTR | 1166 | Q9P2P6 | |
| RRSRRPQVTLLDPNE | 31 | Q9UHQ9 | |
| RRLLEAGANPNQPDR | 1651 | Q99466 | |
| NDRRNAPPVRTENRL | 96 | Q13243 | |
| RLQAQRLRNPDVRGS | 206 | Q9HCE7 | |
| RLRNPDVRGSLQTPQ | 211 | Q9HCE7 | |
| QDVLRRTVQTRPAPR | 551 | Q8N0Z3 | |
| SQPLLQTPRDGGRQR | 11 | O43597 | |
| QPPLQRGTRLRLRQR | 96 | Q9H2A9 | |
| GPRPLLSRAQQRKRD | 71 | C9JXX5 | |
| GRLRRPRQSRFKTQP | 356 | Q7Z7L8 | |
| RNRREGSGNPTPLIN | 236 | Q9NZN8 | |
| NPRPRRIAQRGRNTS | 21 | Q8TC36 | |
| LQTRRPPQRRAAPRS | 741 | Q9BYN7 | |
| EINRRGRRAPPILAN | 316 | Q9UK80 | |
| LRSRQRRQPRPQETE | 106 | Q5JTV8 | |
| VRRVPNLPQRFGRTT | 121 | Q9HCQ7 | |
| LSLSQRLRRTPPAQR | 2411 | Q15772 | |
| RVQRRRVPSASPLIQ | 76 | Q6RVD6 | |
| KQRGRPSSQPRRNIV | 36 | Q9BPZ2 | |
| PEARRNSRQPLEIRT | 176 | Q9NS62 | |
| QDPGLQRRPRHRIQS | 111 | Q6VEQ5 | |
| QDPGLQRRPRHRIQS | 111 | A8K0Z3 | |
| PARTRNLSGEPRTRQ | 2366 | Q5T1R4 | |
| QDPGLQRRPRHRIQS | 111 | C4AMC7 | |
| MVRGARQPQQPRSRL | 1 | Q8N9R8 | |
| LRSVPRNIPRNTERL | 46 | O94813 | |
| RISNLKDPRNPGLRR | 241 | O75764 | |
| QRRRLLVPANEGDPT | 321 | O14763 | |
| LRSEGVQLNPPRARA | 161 | A0A0U1RQS6 | |
| SQRRRLLVPANGADP | 346 | O00220 | |
| ARPQTLNRPGQELFR | 41 | P59923 | |
| PSRVRRLPDGQLQVT | 281 | Q9NNW7 | |
| KVTPRRNRQQRPGTI | 21 | Q8TF42 | |
| TSRPRPERNILVLGN | 411 | Q9C0G0 | |
| AEDEPRGRQLRLQRP | 326 | Q9H4Z2 | |
| ERERREQNLPARPSR | 221 | Q8NG27 | |
| RQRLSARPPLREQRE | 781 | Q07283 | |
| ARPPLREQRERQLRA | 786 | Q07283 | |
| KRPRIQQRPRARVSG | 26 | Q6ZVT0 | |
| RRSLRRRQQPGIELP | 501 | Q96ME7 | |
| PRSRRARQSEEQAPL | 56 | P50607 | |
| TQPRRLLNTLRELNP | 176 | O94782 |